Cargando…

Prognostic Significance of Tripartite Motif Containing 16 Expression in Patients with Gastric Cancer

BACKGROUND AND AIM: Tripartite Motif Containing 16 (TRIM16) is a member of the TRIM protein family which is known to play a suppressor role in development of numerous tumor types. However, a positive correlation between TRIM16 expression and gastric cancer (GC) progress has created a controversial s...

Descripción completa

Detalles Bibliográficos
Autores principales: Afshar, Jalil, Mehrzad, Jamshid, Mehrad-Majd, Hassan, Goshayeshi, Ladan, Saeidi, Jafar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629450/
https://www.ncbi.nlm.nih.gov/pubmed/34452557
http://dx.doi.org/10.31557/APJCP.2021.22.8.2445
_version_ 1784607207627685888
author Afshar, Jalil
Mehrzad, Jamshid
Mehrad-Majd, Hassan
Goshayeshi, Ladan
Saeidi, Jafar
author_facet Afshar, Jalil
Mehrzad, Jamshid
Mehrad-Majd, Hassan
Goshayeshi, Ladan
Saeidi, Jafar
author_sort Afshar, Jalil
collection PubMed
description BACKGROUND AND AIM: Tripartite Motif Containing 16 (TRIM16) is a member of the TRIM protein family which is known to play a suppressor role in development of numerous tumor types. However, a positive correlation between TRIM16 expression and gastric cancer (GC) progress has created a controversial situation that need to be fully delineated. The aim of this study was to assess the expression level of TRIM16 mRNA and its relationship with β-catenin, CyclinD, and BCL2 expression in Iranian GC patients and to investigate its possible association with patients’ overall survival. MATERIALS AND METHODS: The expression level of TRIM16 of fresh primary tumor and adjacent normal tissues in 40 GC patients was evaluated by real-time quantitative PCR method. Moreover, patients were subdivided into high or low expression subgroups based on the TRIM16 expression levels. The relationship between TRIM16 expression level, β-catenin, Cyclin D, BCL2, some clinicopathological data and prognosis of GC patients was also analyzed. RESULTS: qPCR analysis showed a lower level of TRIM16 in GC tissues (fold change=0.351) in comparison to their matched adjacent noncancerous tissues (P<0.001). Contrary to this, the expression levels of β-catenin, Cyclin D, and BCL2 genes were up-regulated in cancerous samples. This may explain the tumor suppressive function of TRIM16 in GC; as reduction in TRIM16 expression leads to the accumulation of mRNAs from β-catenin, Cyclin D, and BCL2 genes and eventually cancer progression. We did not observe any significant correlation between TRIM16 expression and patients’ overall survival. Univariate Cox regression analysis indicated that anemia, weight loss, bleeding, stomach ache, and smoking are statistically associated with overall survival; while, multivariate analysis did not support any correlation. CONCLUSIONS: In sum, this study suggests a tumor suppressive role for TRIM16 in gastric cancer and proposes it as a potential candidate for GC prognosis.
format Online
Article
Text
id pubmed-8629450
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher West Asia Organization for Cancer Prevention
record_format MEDLINE/PubMed
spelling pubmed-86294502021-12-03 Prognostic Significance of Tripartite Motif Containing 16 Expression in Patients with Gastric Cancer Afshar, Jalil Mehrzad, Jamshid Mehrad-Majd, Hassan Goshayeshi, Ladan Saeidi, Jafar Asian Pac J Cancer Prev Research Article BACKGROUND AND AIM: Tripartite Motif Containing 16 (TRIM16) is a member of the TRIM protein family which is known to play a suppressor role in development of numerous tumor types. However, a positive correlation between TRIM16 expression and gastric cancer (GC) progress has created a controversial situation that need to be fully delineated. The aim of this study was to assess the expression level of TRIM16 mRNA and its relationship with β-catenin, CyclinD, and BCL2 expression in Iranian GC patients and to investigate its possible association with patients’ overall survival. MATERIALS AND METHODS: The expression level of TRIM16 of fresh primary tumor and adjacent normal tissues in 40 GC patients was evaluated by real-time quantitative PCR method. Moreover, patients were subdivided into high or low expression subgroups based on the TRIM16 expression levels. The relationship between TRIM16 expression level, β-catenin, Cyclin D, BCL2, some clinicopathological data and prognosis of GC patients was also analyzed. RESULTS: qPCR analysis showed a lower level of TRIM16 in GC tissues (fold change=0.351) in comparison to their matched adjacent noncancerous tissues (P<0.001). Contrary to this, the expression levels of β-catenin, Cyclin D, and BCL2 genes were up-regulated in cancerous samples. This may explain the tumor suppressive function of TRIM16 in GC; as reduction in TRIM16 expression leads to the accumulation of mRNAs from β-catenin, Cyclin D, and BCL2 genes and eventually cancer progression. We did not observe any significant correlation between TRIM16 expression and patients’ overall survival. Univariate Cox regression analysis indicated that anemia, weight loss, bleeding, stomach ache, and smoking are statistically associated with overall survival; while, multivariate analysis did not support any correlation. CONCLUSIONS: In sum, this study suggests a tumor suppressive role for TRIM16 in gastric cancer and proposes it as a potential candidate for GC prognosis. West Asia Organization for Cancer Prevention 2021-08 /pmc/articles/PMC8629450/ /pubmed/34452557 http://dx.doi.org/10.31557/APJCP.2021.22.8.2445 Text en https://creativecommons.org/licenses/by/3.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/ (https://creativecommons.org/licenses/by/3.0/) ) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Afshar, Jalil
Mehrzad, Jamshid
Mehrad-Majd, Hassan
Goshayeshi, Ladan
Saeidi, Jafar
Prognostic Significance of Tripartite Motif Containing 16 Expression in Patients with Gastric Cancer
title Prognostic Significance of Tripartite Motif Containing 16 Expression in Patients with Gastric Cancer
title_full Prognostic Significance of Tripartite Motif Containing 16 Expression in Patients with Gastric Cancer
title_fullStr Prognostic Significance of Tripartite Motif Containing 16 Expression in Patients with Gastric Cancer
title_full_unstemmed Prognostic Significance of Tripartite Motif Containing 16 Expression in Patients with Gastric Cancer
title_short Prognostic Significance of Tripartite Motif Containing 16 Expression in Patients with Gastric Cancer
title_sort prognostic significance of tripartite motif containing 16 expression in patients with gastric cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629450/
https://www.ncbi.nlm.nih.gov/pubmed/34452557
http://dx.doi.org/10.31557/APJCP.2021.22.8.2445
work_keys_str_mv AT afsharjalil prognosticsignificanceoftripartitemotifcontaining16expressioninpatientswithgastriccancer
AT mehrzadjamshid prognosticsignificanceoftripartitemotifcontaining16expressioninpatientswithgastriccancer
AT mehradmajdhassan prognosticsignificanceoftripartitemotifcontaining16expressioninpatientswithgastriccancer
AT goshayeshiladan prognosticsignificanceoftripartitemotifcontaining16expressioninpatientswithgastriccancer
AT saeidijafar prognosticsignificanceoftripartitemotifcontaining16expressioninpatientswithgastriccancer